Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients

ConditionNeoplasms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversitätsklinikum Hamburg-Eppendorf

About this trial

This study aims to create and test an online learning tool to help people with cancer improve their skills in finding and understanding health information online. The main question it aims to answer is:

• Do people with cancer who use the online learning tool improve their skills more than those who don't use the tool?

The investigators will test this idea in a study. The investigators will put people into different groups by chance and compare the results. 660 people with cancer will participate. These people will be chosen to represent different types of cancer.

* Group 1: Uses the online learning too (3 versions) * Group 2: Uses a PDF with the same information * Control Group: Receives no intervention

What Participants Will Do:

Use the online tool or PDF to learn how to find reliable cancer information online.

Answer questions about their digital health skills before starting, after 2 weeks, and after 8 weeks.

Development:

Before the start of the main study the online tool will be developed and tested. The investigators will first show a prototype of the tool to two discussion groups and use their feedback to improve it. Then, experts and people with cancer will test the final version

Eligibility criteria

Qualifiers

cancer diagnosis

sufficient knowledge of the German language as all study content and questionnaires will be in German only

Participants must also have and be able to use a digital device (smartphone, tablet, PC, laptop, etc.) with an internet connection

Confirm consent to participate in the study

Disqualifiers

Patients who are severely cognitively impaired due to their cancer or other illness

Patients who are unable to operate a digital device

Trial design

Treatments tested in this trial

  • intervention group 1.1 - e-learning
  • intervention-group 1.2 - e-learning
  • intervention-group 1.3 - e-learning
  • intervention-group 2 - PDF

Treatment groups

660 Participants
are divided into 5 treatment groups

Sponsors and collaborators

Universitätsklinikum Hamburg-Eppendorf

Lead sponsor

German Cancer Research Center

Collaborator